产品名称
C24:1 Ceramide (d18:2(4E,8Z)/24:1(15Z)), Avanti Research™ - A Croda Brand 860691P, powder
InChI
1S/C42H79NO3/c1-3-5-7-9-11-13-15-17-18-19-20-21-22-23-24-26-28-30-32-34-36-38-42(46)43-40(39-44)41(45)37-35-33-31-29-27-25-16-14-12-10-8-6-4-2/h17-18,27,29,35,37,40-41,44-45H,3-16,19-26,28,30-34,36,38-39H2,1-2H3,(H,43,46)/b18-17-,29-27-,37-35+/t40-,41+/m0
InChI key
RWMLFFULUMHLPQ-WGCGRUQKSA-N
SMILES string
OC[C@@](NC(CCCCCCCCCCCCC/C=C\CCCCCCCC)=O)([H])[C@]([H])(O)/C=C/CC/C=C\CCCCCCCCC
assay
>99% (TLC)
form
powder
packaging
pkg of 1 × 1 mg (860691P-1mg)
manufacturer/tradename
Avanti Research™ - A Croda Brand 860691P
lipid type
sphingolipids
shipped in
dry ice
storage temp.
−20°C
Biochem/physiol Actions
C24:1 Ceramide in a stable isotope form is suitable for a newly described validated liquid chromatography-tandem mass spectrometry methodology for their clinical-scaled measurement.
General description
C24:1 Ceramide (d18:2(4E,8Z)/24:1(15Z)) or N-nervonoyl-D-erythro-sphingosine (d18:2(4E,8Z) base), is a synthetic ceramide derived from sphingosine with nervonic acid.
Packaging
5 mL Amber Glass Screw Cap Vial (860691P-1mg)
Legal Information
Avanti Research is a trademark of Avanti Polar Lipids, LLC
存储类别
11 - Combustible Solids
flash_point_f
No data available
flash_point_c
No data available
Dimple Kauhanen et al.
Analytical and bioanalytical chemistry, 408(13), 3475-3483 (2016-02-29)
Monitoring the levels of the ceramides (Cer) d18:1/16:0, Cer d18:1/18:0, Cer d18:1/24:0, and Cer d18:1/24:1 and ratios thereof in human plasma empowers the prediction of fatal outcome of coronary artery disease (CAD). We describe a validated liquid chromatography-tandem mass spectrometry
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持